Appointment signals focus on continuing to build best-in-class enterprise security and compliance programs, advance ISO 42001 and regulatory readiness, and embed security and AI governance into its regulated-industry roadmap.
Blue Mountain, the leader in GMP-compliant Enterprise Asset Management (EAM) software for life sciences, today announced the appointment of Paul Adams, CISSP, as Chief Information Security Officer (CISO). Adams has led Blue Mountain’s enterprise security and compliance programs.
Adams is a transformational leader who puts security and compliance first, with a focus on infrastructure availability and integrity. He brings more than 25 years of leadership experience in SaaS and technology, spanning enterprise security strategy, security architecture, and cloud infrastructure. He previously spent more than a decade at CrunchTime, where he led enterprise infrastructure while building and running the company’s infrastructure, information security, and GRC programs. Through his career, Adams has guided technology organizations in the transition from founder-led companies to private-equity ownership, and has advised on security due diligence. At Blue Mountain, he has been overseeing the company’s AI reference architecture and governance model, leading security architecture across the RAM and RAM Discover platforms, and driving its ISO 27001, SOC 2, and ISO 42001 programs.
Read More: SalesTechStar Interview with Sahil Rekhi, Chief Revenue Officer at Graia
“AI is rewriting the rules of security in regulated industries. Our life sciences customers require a partner who can meet both the innovation opportunity and strict compliance requirements. Paul has proven he can do both, and his elevation to CISO reflects our commitment to making security a real competitive advantage”, said David H. Rode, Chief Executive Officer of Blue Mountain.
The security stakes in regulated industries have fundamentally shifted. AI is moving faster than validation frameworks were designed to handle, regulatory scrutiny under the EU AI Act and FDA’s AI/ML guidance is intensifying, and customers in life sciences now expect their software partners to operate with the same governance rigor they apply to their own processes.
Read More: SalesTech for Sales Email Engagement – What Works and What Doesn’t
Paul Adams commented, “Regulated industries have always had high stakes for security failures, but AI is compressing the timeline between a gap in governance and a real compliance event. The organizations that will earn and keep customer trust are the ones that treat security as part of the product, not a layer on top of it.”
